4//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4
Accession 0001465825-15-000003
$ELTPCIK 0001053369operating
Filed
May 20, 8:00 PM ET
Accepted
May 21, 3:02 PM ET
Size
6.6 KB
Accession
0001465825-15-000003
Insider Transaction Report
Form 4
NIGALAYE ASHOK G
DirectorChief Scientific Officer10% Owner
Transactions
- Conversion
Common Stock
2015-05-21$0.06/sh+2,000,000$125,000→ 40,442,232 total - Conversion
Warrants
2015-05-21$0.06/sh−2,000,000$125,000→ 2,000,000 totalExercise: $0.06From: 2011-04-25Exp: 2018-04-25→ Common Stock (2,000,000 underlying)
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 3:02 PM ET
- Size
- 6.6 KB